Medicare Enrolled
Dr. Daniel Vanroy, MD
Cardiovascular Disease · Gainesville, FL
Practice pattern: Electrophysiology & Cardiac— Practice combining electrophysiology and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vanroy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vanroy? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vanroy
Dr. Daniel Vanroy is a cardiovascular disease in Gainesville, FL, with 19 years in practice. Based on federal Medicare data, Dr. Vanroy performed 7,974 Medicare services across 4,928 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vanroy received a total of $24,302 from 39 pharmaceutical and/or device companies across 461 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vanroy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 11% volume in FL$ $24,302 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,974
Medicare services
Top 11% in FL for cardiovascular disease
4,928
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~420 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 1,253 | $0 | $1 |
| Electrocardiogram (EKG), 12-lead | 1,172 | $10 | $34 |
| Office visit, established patient (30-39 min) | 1,014 | $90 | $216 |
| Regadenoson injection (Lexiscan) for heart stress test | 693 | $42 | $113 |
| Echocardiogram, transthoracic | 337 | $135 | $414 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 248 | $87 | $236 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 237 | $51 | $142 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 212 | $313 | $798 |
| Remote pacemaker monitoring, 90 days | 195 | $21 | $63 |
| Hospital follow-up visit, high complexity | 146 | $94 | $213 |
| Remote pacemaker/defibrillator monitoring, 90 days | 138 | $16 | $52 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 124 | $320 | $962 |
| Initial hospital admission, high complexity | 123 | $136 | $415 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 114 | $17 | $54 |
| New patient office visit (45-59 min) | 114 | $116 | $334 |
| Injection, midazolam hydrochloride, per 1 mg | 103 | $0 | $1 |
| Hospital follow-up visit, moderate complexity | 94 | $62 | $149 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 92 | $6 | $18 |
| Programming of dual lead pacemaker system | 88 | $56 | $117 |
| Telephone medical discussion with physician, 11-20 minutes | 88 | $67 | $154 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 83 | $8 | $58 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 82 | $26 | $111 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 79 | $1,146 | $2,954 |
| Office visit, established patient, complex (40-54 min) | 76 | $125 | $295 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 72 | $17 | $54 |
| Office visit, established patient (20-29 min) | 69 | $57 | $147 |
| Injection, fentanyl citrate, 0.1 mg | 69 | $1 | $1 |
| Coronary stent placement | 58 | $439 | $1,290 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 55 | $38 | $102 |
| Heart muscle strain imaging | 50 | $28 | $80 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 50 | $8 | $22 |
| Blood test, basic group of blood chemicals (calcium, ionized) | 49 | $13 | $23 |
| Red blood cell concentration measurement | 49 | $2 | $7 |
| Blood count, hemoglobin | 49 | $2 | $7 |
| Ultrasound of heart, follow-up | 39 | $66 | $204 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 39 | $17 | $53 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 39 | $16 | $49 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 37 | $16 | $45 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 37 | $11 | $30 |
| External shock to heart to regulate heart beat | 32 | $85 | $322 |
| Injection, aminophyllin, up to 250 mg | 26 | $8 | $14 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 25 | $2,094 | $5,246 |
| Nuclear medicine study of heart muscle blood flow by pet | 25 | $139 | $355 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 25 | $217 | $731 |
| Blood draw (venipuncture) | 23 | $8 | $10 |
| Coagulation time measurement, activated | 18 | $4 | $12 |
| Programming of single lead pacemaker system | 17 | $45 | $97 |
| EKG interpretation and report | 16 | $6 | $17 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 16 | $114 | $521 |
| Cardiac catheterization | 16 | $737 | $1,940 |
| Programming of dual lead implantable defibrillator system | 15 | $60 | $157 |
| Telephone medical discussion with physician, 5-10 minutes | 15 | $40 | $100 |
| Review by radiologist of abdominal aorta image | 14 | $91 | $274 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 14 | $20 | $54 |
| Heart rhythm recording of continous external ekg over 8-15 days | 11 | $8 | $58 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.3% high complexity
35.1% medium
50.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,302
Total received (2018-2024)
Avg $3,472/year across 7 years
Top 12% in FL for cardiovascular disease
39
Companies
461
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,302 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,165
2023$2,429
2022$1,648
2021$1,883
2020$1,570
2019$8,812
2018$2,795
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$5,123
Abbott Laboratories
$4,300
Medtronic Vascular, Inc.
$2,126
W. L. Gore & Associates, Inc.
$2,094
Cook Medical LLC
$1,881
Penumbra, Inc.
$1,593
Siemens Medical Solutions USA, Inc.
$1,225
Amgen Inc.
$879
ABIOMED
$762
Cardiovascular Systems Inc.
$674
Boston Scientific Corporation
$535
Novartis Pharmaceuticals Corporation
$483
Bard Peripheral Vascular, Inc.
$384
Regeneron Healthcare Solutions, Inc.
$268
Janssen Pharmaceuticals, Inc
$243
AngioDynamics, Inc.
$216
E.R. Squibb & Sons, L.L.C.
$173
Shockwave Medical, Inc
$149
LimFlow Inc.
$135
Chiesi USA, Inc.
$130
Edwards Lifesciences Corporation
$116
Cook Incorporated
$115
PFIZER INC.
$111
Merck Sharp & Dohme LLC
$87
Silk Road Medical, Inc.
$72
AstraZeneca Pharmaceuticals LP
$55
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$52
Lexicon Pharmaceuticals, Inc.
$51
LivaNova USA, Inc.
$48
Organogenesis Inc.
$41
SANOFI-AVENTIS U.S. LLC
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$38
Braemar Manufacturing, LLC
$20
Kiniksa Pharmaceuticals International, plc
$17
Lundbeck LLC
$17
CARDIVA MEDICAL, INC.
$13
Gilead Sciences, Inc.
$13
Cardinal Health 200, LLC
$11
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 47.5% of total payments
Associated products mentioned in payments ›
3F · ADVANCE · AMPLATZ · AURYON LASER SYSTEM 100-120 VAC · AVEIR · AVVIGO Guidance System · Advance · Amplatz · Arcalyst · Artis one · Artis zee · BRILINTA · C3 Delivery System · CAMZYOS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · COBALT DR MRI SURESCAN · COOK · COOK MEDICAL ANGIOPLASTY · COOK MEDICAL BEACON · COOK MEDICAL CATHETERS · COOK MEDICAL FLEXOR ANSEL · COOK MEDICAL INTRODUCERS · COOK MEDICAL STENTS · COOK MEDICAL WIRE GUIDES · COOK MEDICAL ZILVER PTX · COREVALVE EVOLUT R · Cardiac Monitoring Suite · Connect HF · Cook Medical Angioplasty · Cook Medical Balloon-Expanding Stent · Cook Medical Catheters · Cook Medical Peripheral Intervention · Cook Medical Self-Expanding Stent · Cook Medical Tornado · Cook Medical Wire Guides · Cook Medical Zilver PTX · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · Crosser iQ · DXTERITY · Diamondback Peripheral · Dryseal Flex Sheath · ELIQUIS · ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter · ENROUTE Transcarotid Stent · ENTRESTO · EXCLUDER Iliac Branch Endoprosthesis · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · Endurant · Formula 418 · GENERAL STENTS · GENERAL - THERAPIES · GORE EXCLUDER Iliac Branch Endoprosthesis · GORE TAG Conformable Thoracic Endoprosthesis · GORE TAG Conformable Thoracic Stent Graft · GORE TAG Thoracic Branch Endoprosthesis · HAWKONE · HawkOne · IN.PACT Admiral · INTEGRITY · Impella · Indigo · Indigo System · Inpefa · JARDIANCE · KENGREAL · LEQVIO · LIMFLOW SYSTEM · LINQ II · LUTONIX · LUTONIX Drug Coated Balloon · Launcher · LifeVest · MICROPUNCTURE · MULTAQ · Micropuncture · MynxGrip Vascular Closure Device · NESTER · NORTHERA · ONYX FRONTIER · Optis Coronary Imaging System · PERFORMER · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Penumbra Ruby Coil · Penumbra System · Peripheral Orbital Atherectomy System · ProtekDuo · Puraply · Quadra Assura CRT Defibrillator · RESOLUTE ONYX · ROSEN · Repatha · Resolute · SYMPLICITY G3 · TAG Thoracic Endoprosthesis · TELESCOPE · TORCON NB · TORNADO · TRAcelet · TRUE FLOW · Telescope · Torcon NB · TurboHawk · VENOVO · VERQUVO · VYNDAQEL · Vascular Lithotripsy · Venclose Maven Catheter · Venovo · WATCHMAN · WOLVERINE · XARELTO · Xience Sierra Coronary Stent · Xience V coronary stent system · ZILVER PTX · ZILVER VENA · Zilver Vena
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $305 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
44
Per 100K population
15.6
County median income
$59,659
Nearest hospital
HCA FLORIDA NORTH FLORIDA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Vanroy is a electrophysiology & cardiac specialist, with above-average Medicare volume (top 11% in FL), and high industry engagement (low-engagement, top 12%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Vanroy experienced with injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)?
Based on Medicare claims data, Dr. Vanroy performed 1,253 injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vanroy receive payments from pharmaceutical companies?
Yes. Dr. Vanroy received a total of $24,302 from 39 companies across 461 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vanroy's costs compare to other cardiovascular diseases in Gainesville?
Dr. Vanroy's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vanroy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Gainesville
Browse cardiovascular diseases in Gainesville ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology